Certain antidepressants may erode bone, reports the Harvard Mental Health Letter
Evidence is growing that people taking the common antidepressants known as selective serotonin reuptake inhibitors (SSRIs) may be at risk for thin bones, reports the August 2009 issue of the Harvard Mental Health Letter.
In the past few years, well-designed studies have not only built a case for a biological link between bone and the brain, but also suggested that SSRIs may be particularly harmful to bone. Researchers have identified several possible mechanisms linking brain and bone. Studies have reported that depression elevates levels of both the stress hormone cortisol and various immune system cells that promote inflammation—changes that can harm bone. More recently, scientists have discovered that bone cells have receptors for various brain chemicals and may be responsive to changes in the brain.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
